BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 35 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,534,127 | +36.1% | 19,100,000 | +11.7% | 0.00% | 0.0% |
| Q2 2023 | $10,681,544 | +10.3% | 17,100,000 | +13.2% | 0.00% | 0.0% |
| Q1 2023 | $9,684,037 | -27.5% | 15,100,000 | -55.8% | 0.00% | – |
| Q4 2022 | $13,362,580 | +77.0% | 34,200,000 | +100.0% | 0.00% | – |
| Q3 2022 | $7,549,000 | +5.8% | 17,100,000 | +5.9% | 0.00% | – |
| Q2 2022 | $7,135,000 | -14.4% | 16,150,000 | -5.8% | 0.00% | – |
| Q1 2022 | $8,340,000 | – | 17,150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 52,257,000 | $39,745,106 | 8.72% |
| Context Capital Management, LLC | 32,083 | $24,052 | 1.93% |
| BRAIDWELL LP | 67,294,000 | $50,470,500 | 1.60% |
| DeepCurrents Investment Group LLC | 17,855,000 | $13,514,056 | 0.59% |
| Aequim Alternative Investments LP | 20,000,000 | $15,000,000 | 0.57% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,488,000 | $22,116,000 | 0.51% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $3,750,375 | 0.51% |
| ARISTEIA CAPITAL, L.L.C. | 25,280,000 | $18,960,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 8,217,000 | $6,121,665 | 0.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,604,000 | $3,430,520 | 0.49% |